Short-term use of intranasal corticosteroids: Lack of systemic effects [3]

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 3, 2002, Pages 573-574

  Bachert, Claus ^a   Lukat, Karl Friedrich ^b   Lange, Bernd ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Institut fur Atemwegsforschung GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO; TRIAMCINOLONE ACETONIDE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LETTER; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0036130503     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.122236     Document Type: Letter

References (7)

1. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity
2. Treatment of seasonal rhinitis with once-daily intranasal fluticasone propionate therapy in children
3. Fluticasone propionate: Topical or systemic effects
4. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations
5. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects
6. Binding of glucocorticoids to human nasal tissue in vitro
7. Oral bioavailability of fluticasone propionate in healthy subjects